Advertisement

Reactions Weekly

, Volume 1775, Issue 1, pp 372–372 | Cite as

Pembrolizumab

Autoimmune paraneoplastic dermatomyositis: case report
Case report
  • 20 Downloads

Reference

  1. Vandenberghe-Durr S, et al. Dermatomyositis after treatment with antitumor immune checkpoint inhibitor: Improvement with rituximab after TNF blocker failure. Swiss Medical Weekly 149 (Suppl. 238): 2S, Aug 2019. Available from: URL: https://smw.ch/fileadmin/content/supplements/Suppl_Suppl_238.pdf [abstract] - Switzerland

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations